Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marina Acera Gómez
Observed names:
Marina Acera,
Marina Acera-Gómez
Institutions:
Complejo Hospitalario de Salamanca,
Instituto de Investigación Biomédica de Salamanca
Observed institutions:
Universidad de Salamanca,
Complejo Hospitalario de Salamanca,
Instituto de Investigación Biomédica de Salamanca,
Centro de Investigación Biomédica en Red de Cáncer,
Instituto de Biología Molecular y Celular del Cáncer de Salamanca
ORCID:
0000-0002-7474-143X
Observed ORCID:
0000-0002-7474-143X
OpenAlex ID:
A5090333086
Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care
2025
·
Maria Salas
, María Solano
, et al.
·
Frontiers in Immunology
·
15
PDF
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy
2024
·
José Luis Piñana
, Lourdes Vazquez
, et al.
·
Frontiers in Oncology
·
12
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC
2024
·
Virginia Escamilla-Gómez
, Valentín García Gutiérrez
, et al.
·
Bone Marrow Transplantation
·
11
PDF
HCT Frailty Scale (HCT-FS) for assessing frailty in adult candidates for allogeneic haematopoietic cell transplantation: an international prospective, observational cohort study
2026
·
María Queralt Salas
, Tommy Alfaro Moya
, et al.
·
EClinicalMedicine
·
4
Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH ‐ TC study
2025
·
Carles Tolosa‐Ridao
, Mónica Baile González
, et al.
·
British Journal of Haematology
·
4
The Impact of Frailty on Outcomes and Quality of Life in Allogeneic Hematopoietic Cell Transplantation: Summary of Results from a Collaborative Prospective Study Conducted on Behalf of the Geth-TC
2024
·
Maria Queralt Salas
, Maria Teresa Solano
, et al.
·
Blood
·
3
Ruxolitinib in Acute and Chronic Graft-Versus-Host Disease: Real Life Experience in a Multi-Centre Study
2022
·
Virginia Escamilla Gomez
, Valentín García Gutiérrez
, et al.
·
Blood
·
2
Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH‐TC study
2026
·
Javier Cornago
, Mónica Baile
, et al.
·
British Journal of Haematology
·
1
The Frailty Syndrome As Predictor of Allogeneic Hematopoietic Cell Transplantation Outcomes. Prospective Study on Behalf of the Grupo Español De Trasplante Hematopoyético y Terapia Celular
2023
·
Maria Queralt Salas
, Maria Teresa Solano
, et al.
·
Blood
·
1
HCT ‐ FS ‐Defined Frailty Is Associated With Lower Survival Across Diverse Hematologic Diagnoses After Allogeneic Transplantation
2026
·
Tommy Alfaro Moya
, María Queralt Salas
, et al.
·
European Journal Of Haematology
PDF
Outcomes of Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis in Myelodysplastic Syndromes: A Multicenter Study Conducted on Behalf of GETH-TC
2026
·
María Queralt Salas
, Carlos Jiménez-Vicente
, et al.
·
Transplantation and Cellular Therapy
Frailty assessed by HCT-FS predicts survival and non-relapse mortality across hematologic disorders undergoing allo-HCT: A multicenter Study of 992 patients
2025
·
Tommy Alfaro Moya
, Maria Queralt Salas Gay
, et al.
·
Blood
PDF
Co-infections during SARS-CoV-2 infection in hematologic patients and cell therapy recipients in the omicron era: a Spanish hematopoietic stem cell transplantation and cell therapy group study
2025
·
Pedro Chorão
, Alex Avendaño
, et al.
·
BMC Infectious Diseases
PDF
HCT Frailty Scale (HCT-FS) for Assessing Frailty in Allogeneic Hematopoietic Cell Transplant Patients. Results from a Canadian and Spanish Initiative
2025
·
María Queralt Salas
, Tommy Alfaro-Moya
, et al.
·
SSRN Electronic Journal
HCT Frailty Scale (HCT-FS) for Assessing Frailty in Allogeneic Hematopoietic Cell Transplant Patients. Results from a Canadian and Spanish Initiative
2025
·
María Queralt Salas
, Tommy Alfaro-Moya
, et al.
·
SSRN Electronic Journal
Frailty and Outcomes in Multiple Myeloma Patients Eligible for Autologous Hematopoietic Cell Transplantation: A Prospective Study of the Grupo Español De Trasplante Hematopoyético y Terapia Celular (GETH-TC)
2024
·
Maria Queralt Salas
, Maria Teresa Solano
, et al.
·
Blood
Frailty Syndrome in Adults Undergoing Autologous Hematopoietic Cell Transplantation. Prospective Study on Behalf of the Grupo Español De Trasplante Hematopoyético y Terapia Celular
2023
·
Maria Queralt Salas
, Maria Teresa Solano
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
17
Citation count:
53
H-index:
4
I10-index:
3
Year
Topic
Type